Programs
Departments & Divisions
Research
Clinical
Lola C Morgan, M.D.
Professor/Clinical
Dr. Morgan works at UT Health San Antonio and is devoted to caring for people with epilepsy. Her clinics are based at the MARC and University Hospital as well as performing volunteer work as an attending to the Epilepsy Foundation clinics here in Bexar and Uvalde Counties. Dr. Morgan provides comprehensive management in treating epilepsy with medications, device and surgical options. As part of this work, she is the Medical Director of the Neurodiagnostic Center based at University Hospital with a passion for quality and safety that is reflected in our care. Additionally, Dr. Morgan serves as the Co-Director of the South Texas Comprehensive Epilepsy Center and guide the development and goals of our program. Part of her research work has been based in the inpatient setting, serving as site principal investigator on multiple clinical trials dedicated to improving care for status epilepticus. She is active in mentoring the future generation of neurologists and epileptologists and has engaged a wide range of mentees from different levels including neurophysiology fellows, neurology residents, engineering and medical students. The overarching goal of her focus is dedicated to the advancement of the field of epilepsy and providing excellent epilepsy care.
-
Professional Background
Education
- 2000 - MD - Stritch School of Medicine, Loyola University of Chicago
- 1991 - BFA - cello (cum laude) - College Conservatory of Music, University of Cincinnati
Training
- 2005 - Clinical Fellowship - Clinical Neurophysiology EEG/Epilepsy - University of California San Diego
- 2004 - Residency - Adult. Neurology - University of California Los Angeles
- 2001 - Internship - Preliminary Medicine - Maricopa Medical Center
Highlights
11/2019 Bexar County Medical Society Women in Medicine Leadership Award
12/2017 Fellow of the American Epilepsy Society: Designated FAES as recognition for service to the AES
03/2017 ESETT Recognition: "The Pablo Picasso Award" for most creative community consultation and public disclosure of the NIH funded multicenter ESETT trialAppointments
- 09/2020 - Professor - UT Health San Antonio, Neurology, San Antonio
- 9/2014-08/2020 - Associate Professor / Clinical - UT Health San Antonio, Neurology, San Antonio
- 7/2010-06/2012 - Attending - Baptist St. Luke`sSan Antonio
- 1/2009 - Medical Director, Neurodiagnostic Center and Epilepsy Monitoring Unit - University Health SystemSan Antonio
- 8/2007 - Attending Physician - UT Health San Antonio PhysiciansSan Antonio
- 8/2007 - Attending Physician - University Health SystemSan Antonio
-
Instruction & Training
- 08/2010-09/2019, Clinical Neurology Abnormal Examination, UT Health San Antonio
- 01/2010 - 09/2019, Epilepsy Monitoring Unit Nurse Education Series, University Hospital
- 11/2007 - 09/2019, Neurology Board Review, UT Health San Antonio
- 08/2007 - 09/2019, Neurophysiology Fellowship, UT Health San Antonio
-
Research & Grants
Grants
Period: 01/2018 - 12/2018
Funding Agency: Sunovion
Title: STAR Study: to evaluate the effectriveness of ESL administered once daily as the first adjunctive therapy to levetiracetam or lamotriine or as laster adjunctive therapy in subjects with POS over a 24 week maintenance period
Role: Principal InvestigatorPeriod: 01/2016 - 07/2018
Title: Established Status Epilepticus Treatment Trial A multicenter, randomized, blinded, comparative effectiveness study of fosphenytoin, valproic acid, or levetiracetam in the emergency department treatment of patients with benzodiazepine‐refractory sta
Role: Co-InvestigatorPeriod: 01/2015 - 01/2018
Title: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study To Evaluate The Efficacy And Safety of Lacosamide As Adjunctive Therapy For Uncontrolled Primary Generalized Tonic-Clonic Seizures In Subjects With Idiopathic Generalized E
Role: Co-InvestigatorPeriod: 01/2015 - Present
Title: A Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Sage-547 Injection In The Treatment Of Subjects With Super-Refractory Status Epilepticus
Role: Co-Principal InvestigatorPeriod: 01/2015 - Present
Title: An open-label, multicenter extension study to evaluate the long-term safety and efficacy of lacosamide as adjunctive therapy for uncontrolled primary generalized tonic-clonic seizures in subjects with idiopathic generalized epilepsy (EP0012)
Role: Co-InvestigatorPeriod: / - Present
Title: ESETT (Established Status Epilepticus Treatment Trial) :A Multicenter, Randomized, Blinded, Comparative Effectiveness Study of Fosphenytoin, Valproic Acid, or Levetiracetam in the Emergency Department Treatment of Patients With Benzodiazepine-refractory
Role: Co-Investigator -
Service
Department
Co-Medical Director of the South Texas Comprehensive Epilepsy Center (2013-present)
Director, Neurophysiology Fellowship (2012-2013)
Medical Director, Neurodiagnostic Center University Hospital (2009-present)School
Medical School Admissions Committee
Neurology Residenty Committee
Neurophysiology Fellowship CommitteeInstitutional
Medical Director, Clinical Management Team, University Hospital
Community
Course Director, "Seizures and Epilepsy: An Update for People with Epilepsy or Seizure Disorders and Their Caregivers"
Epilepsy Foundation Central & South Texas -
Publications
-
Clinical
Board Certifications
- 2013 - American Board of P&Neurology in Epilepsy
- 2007 - American Board of P&N/Clinical Neurophysiology
- 2006 - American Board of P&N/Neurology